Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 31, 2026 19:04 ET | Source: Alberta Dental Association

Your Next Dental Appointment May Save Your Life

EDMONTON, Alberta, March 31, 2026 (GLOBE NEWSWIRE) -- When you sit down for a routine dental visit, your oral health professional is doing more than checking your teeth. They are also examining the...
March 31, 2026 07:26 ET | Source: Geotab

Geotab and Hyundai partner to deliver hardware-free, native telematics integration

PARIS, March 31, 2026 (GLOBE NEWSWIRE) -- Geotab, a global leader in connected vehicle solutions, today announced the launch of its integrated solution for Hyundai vehicles across Europe. By...
March 30, 2026 08:05 ET | Source: iRhythm

Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform

Data presented at ACC.26 demonstrate a high prevalence of clinically actionable arrhythmias across CKM patient populations using Zio® ambulatory ECG
March 23, 2026 08:05 ET | Source: NKGen Biotech, Inc.

NKGen Biotech Reports Combined Phase 1 Troculeucel Data Demonstrating Dose-Responsive Cognitive Improvements and Biomarker Correlations in Alzheimer’s Disease at AD/PD 2026™

Pooled analyses in patients with moderate Alzheimer’s show dose-related cognitive benefit and signs of durability. 100% of patients remained stable or improved, with 50% improving from moderate to...
March 23, 2026 07:30 ET | Source: Anavex Life Sciences Corp.

Anavex Life Sciences Presents New Data from its AD-004 Phase IIb/III Trial at AD/PD 2026 Conference Demonstrating Consistent Correlation Between the Treatment Effect of Oral Blarcamesine and Preservation of Brain Volume in Early Alzheimer’s Disease

New data show brain-volume preservation correlates with patient outcomes Long-term clinical data indicate 77.4 weeks (17.8 months) time saved with oral blarcamesine compared to ADNI1 control group...
March 20, 2026 06:58 ET | Source: Research and Markets

U.S. Dental 3D Printing Market to Reach $8.49 Billion by 2033 - Rising Tooth Loss Challenges Drive Dental Procedures Adoption

Dublin, March 20, 2026 (GLOBE NEWSWIRE) -- The "U.S. Dental 3D Printing Market Size, Share & Trends Analysis Report by Application, Technology, Material, End-use, and Segment Forecasts,...
March 18, 2026 08:30 ET | Source: Amarin Corporation plc

Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline

DUBLIN and BRIDGEWATER, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin”), a company committed to advancing the science of cardiovascular disease (CVD)...
March 13, 2026 07:42 ET | Source: Research and Markets

Strimvelis (Orchard Therapeutics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Strimvelis Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering....
March 12, 2026 05:10 ET | Source: Research and Markets

$19.81 Bn AI Medical Diagnosis App Markets, 2026-2040 Industry Trends and Global Forecasts - Federated Learning and Explainable AI Lead the Way

Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "AI Medical Diagnosis App Market, till 2040: Distribution by Mode of Deployment, Application, Type of End User and Key Geographical Regions: Industry...
March 11, 2026 08:45 ET | Source: Callan JMB Inc.

Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech’s IND Clinical Trials for lodonal™ in the Treatment of Long COVID

Callan JMB will Provide Independent Manufacturing Oversight and Governance as lodonal™ Undergoes Clinical Trials for Underserved Patient Population SPRING BRANCH, Texas, March 11, 2026 (GLOBE...